Which of the following statements about nateglinide is TRUE?
It is a long acting oral hypoglycemic drug Taken just before a meal, it limits post prandial hyperglycemia in type 2 diabetes mellitus It cannot be used in patients with renal impairment It acts by opening K+ channels in myocytes and adipocytes